Latent HHV-6B infection of astrocytes may increase the risk of depression by activating the HPA axis

In All, CNS Disease by Kristin Loomis

Little is known about the effects of the proteins HHV-6A/B produce during latency. Researchers, led by Kazuhiro Kondo, MD, PhD at Jikei University School of Medicine, identified a protein named SITH-1 that they believe greatly increases the risk of depression by prolonging hypothalamic-pituitary-adrenal (HPA) axis activation. The HPA axis hyperactivation for prolonged periods can lead to depressive symptoms. 

In mice, expression of the HHV-6B SITH-1 protein was found to increase apoptosis in the olfactory bulb, thereby suppressing hippocampal neurogeneration, which activates the HPA axis and leads to depressive symptoms. In human astrocyte cell lines, SITH-1 was found to form a complex with CAML, a calcium modulator. The SITH-CAML complex increased the intracellular concentration of calcium enough to induce apoptosis in human astrocytes. To assess the prevalence of SITH-CAML in depressive patients, levels of anti-SITH-CAML antibodies were measured and compared to healthy controls. The positive rates of the antibodies were 79.8% in depressive patients and 24.4% in controls, with an odds ratio of 12.2. Anti-SITH-CAML antibodies were 77.7% accurate as a diagnostic marker for depression. 

The research builds off Dr. Kondo’s previous research that found 88% of stressed office workers were positive for reactivated HHV-6 before the holidays, but only 23% were positive after the holidays. Looking for a potential mechanism, Kondo assessed SITH-1 dependent mental status changes and found that manic behavior could be induced by SITH-1 expression in glial cells in mice. He then reported that over half of depressed patients and three-quarters of bipolar patients were positive for anti-SITH-1 antibodies. 

 By demonstrating that HHV-6B can lately infect olfactory neurons, produce a unique protein that triggers apoptosis of hippocampal neurons, and induce prolonged activation of the HPA axis, Kondo et al have provided a novel groundwork for future research in depression. Additionally, they have identified a novel cellular pathway that may help researchers better understand the effects of latent herpesvirus infections that are highly prevalent throughout the population.

Read the full paper: Kobayashi 2020